The small-cap arm of London-based buyout firm Bridgepoint Capital has sealed a quick and healthy return from the sale of a drugs development company it bought two years ago.

Bridgepoint Development Capital has sold Quotient Clinical to fellow London-based private equity firm GHO Capital, according to a statement on December 2.